Article

Hematopoietic cells and osteoblasts are derived from a common marrow progenitor after bone marrow transplantation

Division of Experimental Hematology, St. Jude Children's Research Hospital, 332 North Lauderdale Street, Memphis, TN 38105, USA.
Proceedings of the National Academy of Sciences (Impact Factor: 9.81). 09/2004; 101(32):11761-6. DOI: 10.1073/pnas.0404626101
Source: PubMed

ABSTRACT Bone and bone marrow are closely aligned physiologic compartments, suggesting that these tissues may represent a single functional unit with a common bone marrow progenitor that gives rise to both osteoblasts and hematopoietic cells. Although reports of multilineage engraftment by a single marrow-derived stem cell support this idea, more recent evidence has challenged claims of stem cell transdifferentiation and therefore the existence of a multipotent hematopoietic/osteogenic progenitor cell. Using a repopulation assay in mice, we show here that gene-marked, transplantable marrow cells from the plastic-nonadherent population can generate both functional osteoblasts/osteocytes and hematopoietic cells. Fluorescent in situ hybridization for the X and Y chromosomes and karyotype analysis of cultured osteoblasts confirmed the donor origin of these cells and excluded their generation by a fusion process. Molecular analysis demonstrated a common retroviral integration site in clonogenic hematopoietic cells and osteoprogenitors from each of seven animals studied, establishing a shared clonal origin for these ostensibly independent cell types. Our findings indicate that the bone marrow contains a primitive cell able to generate both the hematopoietic and osteocytic lineages. Its isolation and characterization may suggest novel treatments for genetic bone diseases and bone injuries.

Download full-text

Full-text

Available from: Ted J Hofmann, Sep 03, 2015
0 Followers
 · 
126 Views
 · 
33 Downloads
  • Source
    • "Which stage in the development of marrow cells do these cells represent is difficult to say, also because they have only some features in common with other subpopulations identified in the murine bone marrow [120, 121]. It is noteworthy to mention that several studies in mice have shown that nonadherent HSPCs that can reconstitute the blood are also capable to give rise to osteoblasts [122, 123]. The Krause group has demonstrated in mice that nonhematopoietic (lin−) BM cells are the primary source of donor-derived lung epithelial cells by showing that they consistently give rise to surfactant protein C (SPC) positive lung epithelial cells in SPC-knockout recipient mice, while hematopoietic BM cells do not [124]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Chronic lung diseases, such as cystic fibrosis (CF), asthma, and chronic obstructive pulmonary disease (COPD) are incurable and represent a very high social burden. Stem cell-based treatment may represent a hope for the cure of these diseases. In this paper, we revise the overall knowledge about the plasticity and engraftment of exogenous marrow-derived stem cells into the lung, as well as their usefulness in lung repair and therapy of chronic lung diseases. The lung is easily accessible and the pathophysiology of these diseases is characterized by injury, inflammation, and eventually by remodeling of the airways. Bone marrow-derived stem cells, including hematopoietic stem/progenitor cells (HSPCs) and mesenchymal stromal (stem) cells (MSCs), encompass a wide array of cell subsets with different capacities of engraftment and injured tissue regenerating potential. Proof-of-principle that marrow cells administered locally may engraft and give rise to specialized epithelial cells has been given, but the efficiency of this conversion is too limited to give a therapeutic effect. Besides the identification of plasticity mechanisms, the characterization/isolation of the stem cell subpopulations represents a major challenge to improving the efficacy of transplantation protocols used in regenerative medicine for lung diseases.
    The Scientific World Journal 01/2014; 2014:859817. DOI:10.1155/2014/859817 · 1.73 Impact Factor
  • Source
    • "Hematopoietic stem cells (HSC) are adult stem cells that contain the potentiality in self-renew and differentiation into specialized blood cells that function in some biological activities: control homeostasis balance, immune function, and response to microorganisms and inflammation. HSCs can also differentiate into other specialized cell or so called plasticity such as adipocytes [1], cardiomyocytes [2], endothelial cells [3], fibroblasts/myofibroblasts [4], liver cells [5, 6], osteochondrocytes [7, 8], and pancreatic cells [9]. Most HSCs are in quiescent state within the niches that maintain HSC pool and will respond to the signals after the balance of blood cells or HSC pool is disturbed from either intrinsic or extrinsic stimuli. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Hematopoietic stem cells (HSCs) play a key role in hematopoietic system that functions mainly in homeostasis and immune response. HSCs transplantation has been applied for the treatment of several diseases. However, HSCs persist in the small quantity within the body, mostly in the quiescent state. Understanding the basic knowledge of HSCs is useful for stem cell biology research and therapeutic medicine development. Thus, this paper emphasizes on HSC origin, source, development, the niche, and signaling pathways which support HSC maintenance and balance between self-renewal and proliferation which will be useful for the advancement of HSC expansion and transplantation in the future.
    07/2012; 2012:270425. DOI:10.1155/2012/270425
  • Source
    • "Indeed, it may or may not inXuence the choice of manipulating bone marrow aspirates, in order to obtain an adequate amount of osteogenic MSCs as an essential requirement for the success of bone tissue engineering or cell therapy. Relatively few papers have been published on this issue, and the results obtained by various authors suggest that in nonadherent bone-marrow compartment there is an undiVerentiated quiescent subpopulation of mesenchymal progenitors that may become adherent in vitro, begin to proliferate, and diVerentiate into diverse tissue lineages besides bone, as well as rescue in vivo lethally irradiated mice (Falla et al. 1993; Eipers et al. 2000; Dominici et al. 2004; Mödder and Khosla 2008; Zhang et al. 2009). Nevertheless, the diVerence among the 'early adherent' (EA), 'nonadherent' (NA), and 'late adherent' (LA) bone marrow stromal cells has not been fully elucidated. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The nonadherent (NA) population of bone-marrow-derived mononuclear cells (MNC) has been demonstrated to be a source of osteogenic precursors in addition to the plastic-adherent mesenchymal stromal cells (MSC). In the current study, two subpopulations of late adherent (LA) osteoprogenitors were obtained by subsequent replating of NA cells, and their phenotypic, functional, and molecular properties were compared with those of early adherent (EA) MSC. Approximately 35% of MNC were LA cells, and they acquired a homogeneous expression of MSC antigens later than EA cells. In EA-MSC, the alkaline phosphatase (ALP) activity increased significantly from time of seeding to the first confluence, whereas in LA cells it raised later, after the addition of mineralization medium. All subpopulations were able to produce type I collagen and to deposit extracellular matrix with organized collagen fibrils. The proportion of large colonies with more than 50% of ALP positive cells as well as the calcium content was higher in LA than in EA cells. Molecular analysis highlighted the upregulation of bone-related genes in LA-MSC, especially after the addition of mineralization medium. Our results confirm that bone marrow contains LA osteoprogenitors which exhibit a delay in the differentiation process, despite an osteogenic potential similar to or better than EA-MSC. LA cells represent a reservoir of osteoprogenitors to be recruited to gain an adequate bone tissue repair and regeneration when a depletion of the most differentiated component occurs. Bone tissue engineering and cell therapy strategies could take advantage of LA cells, since an adequate amount of osteogenic MSCs may be obtained while avoiding bone marrow manipulation and cell culture expansion.
    Histochemie 09/2009; 132(5):547-57. DOI:10.1007/s00418-009-0633-x · 2.93 Impact Factor
Show more